Enhancing Care and Prevention in HIV Vaccine Trials: An International, Interdisciplinary Collaboration (2009)
Principal Investigator: Peter Newman, Factor-Inwentash Faculty of Social Work, University of Toronto
Funded by: CIHR – Emerging Team Grants LOI
The discovery of a safe and effective preventive vaccine is the best hope for controlling the global AIDS epidemic. To that end, clinical trials involving thousands of human volunteers will need to be conducted for the foreseeable future. Efficacy trials (to determine if a vaccine is effective in preventing HIV infection or not), in particular, involve high-risk volunteers often from vulnerable communities, and mitigate social, behavioural and health risks among volunteers in HIV vaccine trials – in Canada, India, Kenya, South Africa and Thailand. The purpose of the research program is to build an evidence base to ensure that highest standards of care and prevention in safe, ethically and justly conducted HIV vaccine trials.